Jasper Therapeutics Inc (JSPR)
22.98
+0.14
(+0.59%)
USD |
NASDAQ |
May 17, 16:00
22.98
0.00 (0.00%)
After-Hours: 20:00
Jasper Therapeutics Cash from Financing (Quarterly): 47.35M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 47.35M |
| December 31, 2023 | -0.271M |
| September 30, 2023 | 0.036M |
| June 30, 2023 | -0.305M |
| March 31, 2023 | 101.51M |
| December 31, 2022 | 0.028M |
| September 30, 2022 | 0.001M |
| Date | Value |
|---|---|
| June 30, 2022 | 0.013M |
| March 31, 2022 | 0.013M |
| December 31, 2021 | -0.909M |
| September 30, 2021 | 91.73M |
| June 30, 2021 | -0.60M |
| March 31, 2021 | 10.75M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.909M
Minimum
Dec 2021
101.51M
Maximum
Mar 2023
19.18M
Average
0.013M
Median
Mar 2022
Cash from Financing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.597M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 4.005M |
| Theriva Biologics Inc | 0.00 |
| Oragenics Inc | -0.1806M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -15.74M |
| Cash from Investing (Quarterly) | -0.025M |
| Free Cash Flow | -57.73M |
| Free Cash Flow Per Share (Quarterly) | -1.182 |
| Free Cash Flow Yield | -21.62% |